MSL
CELG

Mackay Shields LLC’s Celgene Corp CELG Stock Holding History

Mackay Shields LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-128,896
Closed -$12.8M – 1530
2019
Q3 		$12.8M Buy
128,896
+22,604
+21% +$2.15M 0.08% 292
2019
Q2 		$9.82M Sell
106,292
-290,514
-73% -$27.6M 0.07% 341
2019
Q1 		$37.4M Sell
396,806
-31,104
-7% -$2.72M 0.27% 80
2018
Q4 		$27.4M Buy
427,910
+226,493
+112% +$16.7M 0.22% 97
2018
Q3 		$18M Buy
201,417
+31,179
+18% +$2.76M 0.14% 204
2018
Q2 		$13.5M Sell
170,238
-100,324
-37% -$8.33M 0.09% 278
2018
Q1 		$24.1M Buy
+270,562
New +$26M 0.15% 164

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Mackay Shields LLC's CELG Position: Q4 2019 in Review

Mackay Shields LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 128,896 shares — an estimated $12.8M sold.

Mackay Shields LLC first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $37.4M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mackay Shields LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 128,896 Celgene Corp shares in Q4 2019, an estimated $12.8M.
  • Mackay Shields LLC first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Mackay Shields LLC's Celgene Corp position peaked at $37.4M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mackay Shields LLC's 13F filing for Q4 2019, filed 11 Feb 2020.